Altered splenic [(89)Zr]Zr-rituximab uptake in patients with interstitial lung disease not responding to rituximab: could this indicate a splenic immune-mediated mechanism?

Rituximab (RTX) for immune-mediated inflammatory disease (IMID) with interstitial pneumonitis (IP) results in non-response in about a third of patients for reasons not well understood. Complete peripheral B-cell depletion in IMID-IP does not seem to correlate with successful treatment outcome. A hyp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Nucl Med Mol Imaging
Main Authors: Adams, Human, Meek, Bob, van de Garde, Ewoudt MW, van Moorsel, Coline HM, Vugts, Danielle J, Keijsers, Ruth G, Grutters, Jan C
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7486548/
https://ncbi.nlm.nih.gov/pubmed/32929395
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados